Nephrogenic ascites: Analysis of 16 cases and review of the literature

Medicine

Volumn 77, Issue 4, 1998, Pages 233-245

  Han, Steven Huy B ^a   Reynolds, Telfer B ^a   Fong, Tse Ling ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; CORTICOSTEROID;

ADULT; AGED; ASCITES; ASCITES FLUID; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LAPAROSCOPY; LIVER BIOPSY; MALE; NEPHRECTOMY; PERITONEUM VEIN SHUNT; PRIORITY JOURNAL; REVIEW; SURVIVAL;

ADULT; AGED; ASCITES; BIOPSY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEUM; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 0031843787     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199807000-00002     Document Type: Review

References (64)

1. Arismendi G, Izard MW, Hampton W, Maher JF. The clinical spectrum of ascites associated with maintenance dialysis Am J Med 60: 46-51, 1976.
2. Asscher AW, Anson SG. A vascular permeability factor of renal origin. Nature 198: 1097-99, 1963.
3. Bansal VK, Popli S, Ing TS, Hano JE, Geis WP, Kamadana MR. Intraperitoneal infusion of a non-absorbable steroid in haemodialysis-associated ascites. J Dial 2: 379-85, 1978.
4. Besbas N, Soylemezoglu O, Saatci U, Bakkaloglu A, Arslan S, Gogus S, Topaloglu R. Peritoneal hemosiderosis in pediatric patients with nephrogenic ascites. Nephron 62: 292-95, 1992.
5. Bichler T, Dudley DA, Nephrogenous ascites. Am J Gastroenterol 77: 73-74, 1982.
6. Buselmeier TJ, Simmons RL, Duncan DA, Toledo LH, Mauer SM, Matas AJ, Hong C, Najarian JS, Kjellstrand CM. Local steroid treatment of intractable ascites in dialysis patients. Proc Clin Dial Transplant Forum 5: 9-11, 1975.
7. Cadnapaphomchai P, Kuruvila KC, Holmes J, Schrier RW. Analysis of 5 year experience of home dialysis as a treatment modality for patients with end-stage renal failure. Am J Med 57: 789-99, 1974.
8. Cinque TJ, Letteri J. Idiopathic ascites: Complication of extracorporeal dialysis [abstract]. American Society of Nephrology (Washington, DC) 4: 16, 1970.
9. Cinque TJ, Letteri JM. Idiopathic ascites in chronic renal failure. N Y State J Med 73: 781-84, 1973.
10. Cintin C, Joffe P. Nephrogenic ascites. Case report and review of the literature. Scand J Urol Nephrol 28: 311-14, 1994.
11. Craig R, Sparberg M, Ivanovich P, Rice L, Dordal E. Nephrogenic ascites. Arch Intern Med 134: 276-79, 1974.
12. Cuthbert MF, Peart WS. Studies on the identity of a vascular permeability factor of renal origin. Clin Sci 38: 309-25, 1970.
13. Feingold LN, Gutman RA, Walsh FX, Gunnells JC. Control of cachexia and ascites in hemodialysis patients by binephrectomy. Arch Intern Med 134: 989-97, 1974.
14. Giannone G, Glabman S, Burrows L. Treatment of refractory ascites in hemodialysis patient with peritoneo-venous shunt (Denver shunt). Mt Sinai J Med 50: 256-57, 1983.
15. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladomiu L, Rimola A, Morillas R. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 325: 829-35, 1991.
16. Gluck Z, Nolph KD. Ascites associated with end-stage renal disease. Am J Kidney Dis 10: 9-18, 1987.
17. Gotloib L, Servadio C. Ascites in patients undergoing maintenance hemodialysis. Report of six cases and physiopathologic approach. Am J Med 61: 465-70, 1976.
18. Gutch CF, Mahony JF. Pingerra W, Holmes JH, Ramirez G, Ogden DA. Refractory ascites in chronic dialysis patients. Clin Nephrol 2: 59-62, 1974.
19. Gutch CF, Mahony JF, Pingerra W, Holmes JH, Kolff WJ. Ascites in hemodialysis patients [abstract]. American Society of Nephrology (Washington, DC) 5: 30, 1971.
20. Harber M, Page C, Streather C, O'Doherty M, Barton I. Restoration of peritoneal lymphatic drainage leading to spontaneous resolution of haemodialysis ascites. Nephrol Dial Transplant 9: 716-17, 1994.
21. Hida M, Takamiya T, Kitajima N. A case of peritoneal-extracorporeal shunting for refractory hemodialysis ascites. Tokai J Exp Clin Med 12: 79-81, 1987.
22. Hobar PC, Turner WW Jr, Valentine RJ. Successful use of the Denver peritoneovenous shunt in patients with nephrogenic ascites. Surgery 101: 161-64, 1987.
23. Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med 102: 260-73, 1983.
24. Holm A, Rutsky EA, Aldrete JS. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases. Am Surg 55: 645-52, 1989.
25. Horina JH, Hammer HF, Reisinger EC, Enzinger GF, Holzer H, Krejs GJ. Spontaneous bacterial peritonitis in a hemodialysis patient with systemic lupus erythematosus. Nephron 65: 633-35, 1993.
26. Horn S, Holzer H, Horina JH. Spontaneous bacterial peritonitis in a patient with nephrogenic ascites during an episode of acute renal transplant rejection. Am J Kidney Dis 27: 441-43, 1996.
27. Ing TS, Daugirdas JT, Popli S, Kheirbek AO, Humayin HM, Gandhi VC, Chapa SM. Treatment of refractory hemodialysis ascites with maintenance peritoneal dialysis. Clin Nephrol 15: 198-202, 1981.
28. Jones BF, Trevillian PR, Nanra RS. Idiopathic ascites of haemodialysis: Response to treatment. Br Med J 1: 877, 1976.
29. Korzets A, Danby P, Feehally J, Walls J. CAPD: Successful use in the treatment of nephrogenic ascites. Nephrol Dial Transplant 4: 918-19, 1989.
30. Kuri K, Lee M. Eosinophilic gastroenteritis manifesting with ascites. South Med J 87: 956-57, 1994.
31. LeVeen HH, Wapnick S, Grosberg S, Kinney MJ. Further experience with peritoneo-venous shunt for ascites. Ann Surg 184: 574-81, 1976.
32. Mahony J, Pingerra W, Holmes J, Klein M, Gutch C, Kolff W. Ascites during maintenance hemodialysis [abstract]. Fifth International Congress on Nephrology (Mexico City, Mexico), p 21, 1972.
33. Mahony JF, Gutch CF, Holmes JH. Intractable ascites in chronic dialysis patients [abstract]. American Society of Nephrology (Washington, DC) 4: 51, 1970.
34. Mauk PM, Schwartz JT, Lowe JE, Smith JL, Graham DY. Diagnosis and course of nephrogenic ascites. Arch Intern Med 148: 1577-79, 1988.
35. McLaughlin K, Butt G, Madi A, McMillan M, Mactier R. Sclerosing peritonitis occurring in a hemodialysis patient. Am J Kidney Dis 27: 729-32, 1996.
36. Moore ES, Chung EE, Cevallos EE. Intractable ascites in a child during peritoneal dialysis. J Pediatr 91: 949-51, 1977.
37. Morgan AG, Sivapragasam S, Fletcher P, Terry SI. Hemodynamic improvement after peritoneovenous shunting in nephrogenic ascites. South Med J 75: 373-74, 1982.
38. Morgan AG, Terry SI. Impaired peritoneal fluid drainage in nephrogenic ascites. Clin Nephrol 15: 61-65, 1981.
39. Nicholls AJ, Platts MM, Triger DR. Regular reinfusion of ascites during haemodialysis in a patient with amyloidosis. Br Med J 287: 726, 1983.
40. Nomura S, Osawa G, Karai M. Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin. Nephron 55: 210-13, 1990.
41. Okada K, Takahashi S, Higuchi T, Maeda H. Long-term effect of intravenous reinfusion of unmodified autogenous peritoneal fluid combined with hemodialysis in a patient with dialysis-related ascites [letter]. Nephron 65: 474-75, 1993.
42. Olivero JL. Ascites and malnutrition in a chronic dialysis patient. Hosp Pract 28: 61-62, 1993.
43. Pascual JF, Melendez MT, Rivera-Viera JF. Local steroid therapy of refractory ascites associated with dialysis. J Pediatr 94: 319-20, 1979.
44. Popli S, Chen WT, Nakamoto S, Daugirdas JT, Cespedes LE, Ing TS. Hemodialysis ascites in anephric patients. Clin Nephrol 15: 203-5, 1981.
45. Price DA, Owen WF. African-Americans on maintenance dialysis: A review of racial differences in incidence, treatment, and survival. Adv Ren Replace Ther 4: 3-12, 1997.
46. Quismorio FP. Immune complexes in the pericardial fluid in systemic lupus erythematosus. Arch Intern Med 140: 112-14, 1980.
47. Rector WG, Reynolds TB. Superiority of serum-ascites albumin difference over the ascites total protein concentration in separation of "transudative" and "exudative" ascites. Am J Med 77: 83-85, 1984.
48. Reynolds TB. Renaissance of paracentesis in the treatment of ascites. Adv Intern Med 35: 365-74, 1990.
49. Rocco VK, Ware AJ. Cirrhotic ascites. Pathophysiology, diagnosis, and management. Ann Intern Med 105: 573-85, 1986.
50. Rodriguez HJ, Walls J, Slatopolsky E, Klahr S. Recurrent ascites following peritoneal dialysis. A new syndrome? Arch Intern Med 134: 283-87, 1974.
51. Roy-Chaudhury P, Edward N. ACE inhibitors in the management of haemodialysis ascites [letter]. Nephrol Dial Transplant 9: 1695-96, 1994.
52. Rubin J, Kiley J, Ray R, McFarland S, Bower J. Continuous ambulatory peritoneal dialysis. Treatment of dialysis-related ascites. Arch Intern Med 141: 1093-95, 1981.
53. Runyon BA. Ascites in spontaneous bacterial peritonitis. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease. Pathophysiology/diagnosis/management. 5th ed. Philadelphia: WB Saunders, p 1977, 1993.
54. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 117: 215-20, 1992.
55. Shin KD, Ing TS, Popli S, Daugirdas JT, Ghantous WN, Vilbar RM, Geis P, Hano JE. Isolated ultrafiltration in the treatment of dialysis ascites. Artif Organs 3: 120-23, 1979.
56. Shyh TP, Beyer MM, Friedman EA. Treatment of the uremic diabetic. Nephron 40: 129-38, 1985.
57. Singh S, Mitra S, Berman L. Ascites in patients on maintenance hemodialysis. Nephron 12: 114-20, 1974.
58. Stoerk HC, Laragh JH, Aceto RM, Budzilovich T. Edema and ascites following the ligation of both ureters in rats. Am J Pathol 51-61, 1970.
59. Twardowski ZJ, Alpert MA, Gupta RC, Nolph KD, Madsen BT. Circulating immune complexes: Possible toxins responsible for serositis (pericarditis, pleuritis, and peritonitis) in renal failure. Nephron 35-190-95, 1983.
60. Wang F, Pillay VKG, Ing TS, Armbruster KFW, Rosenberg JC. Ascites in patients treated with maintenance hemodialysis. Nephron 12: 105-13, 1974.
61. Wapnick S, Grosberg S, Kinney M, Azzara V, LeVeen HH. Renal failure in ascites secondary to hepatic, renal, and pancreatic disease. Treatment with a LeVeen peritoneovenous shunt. Arch Surg 113: 581-85, 1978.
62. Woodridge TD, Bower JD, Holbert RD, Ruvinsky MJ. LeVeen shunt (LS): Long-term therapy for idiopathic ascites of chronic renal failure. Proc Clin Dial Transplant Forum 6: 36-39, 1976.
63. Yen MC, Stewart EH. Peritoneo-venous shunt for ascites associated with maintenance dialysis. Clin Nephrol 8: 446-48, 1977.
64. Zerefos N, Duffy B, Chrysant S, Kastagir B, Tauber J, Lavender AR. Dialysis ascites: A new syndrome? [abstract]. Fifth International Congress on Nephrology (Mexico City, Mexico), p 16, 1972.